Transdermal Rotigotine User Surveillance Study

CompletedOBSERVATIONAL
Enrollment

2,195

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Idiopathic Parkinson Disease
Trial Locations (211)

Unknown

813, Chomutov

808, Hradec Králové

822, Hradec Králové

811, Litomyšl

803, Ostrava-Poruba

809, Pardubice

817, Písek

814, Plzen-Lochotin

804, Prague

805, Prague

825, Prague

829, Prague

832, Rakovník

819, Zlín

752, Aalborg

751, Aarhus

750, Sønderborg

242, Aalen

143, Achim

240, Alzenau in Unterfranken

145, Annaberg-Buchholz

245, Aschaffenburg

185, Augsburg

130, Bad Neustadt an der Saale

131, Bamberg

103, Berg

102, Berlin

110, Berlin

113, Berlin

119, Berlin

142, Berlin

150, Berlin

157, Berlin

163, Berlin

166, Berlin

195, Berlin

198, Berlin

206, Berlin

207, Berlin

224, Berlin

243, Berlin

108, Bielefeld

127, Bielefield

178, Blankenburg (Harz)

149, Bochum

151, Bochum

216, Bochum

203, Böblingen

220, Brandenburg

236, Butzbach

237, Butzbach

124, Cologne

153, Cologne

179, Cologne

133, Dresden

199, Dresden

232, Dresden

219, Duisburg

112, Düsseldorf

141, Düsseldorf

152, Eisleben Lutherstadt

129, Emmendingen

162, Erbach im Odenwald

202, Flensburg

156, Friedberg (Hessen)

247, Gera

223, Greifswald

249, Hagen

167, Halle

121, Hamburg

140, Hamburg

176, Hamburg

217, Hamburg

241, Heidenheim

138, Hemmoor

173, Herborn

214, Jena

248, Jena

181, Jülich

105, Karlstadt am Main

106, Karlstadt am Main

244, Kassel

175, Leutkirch

230, Magdeburg

235, Mannheim

148, München

189, München

191, München

169, Naumburg

182, Neuburg am Inn

118, Oberhausen

164, Oberursel (Taunus)

171, Oldenburg

196, Oranienburg

114, Rheda-Wiedenbrück

188, Rottenburg Am Neckar

187, Schriesheim

107, Schwerin

134, Singen

229, Stadtroda

180, Starnberg

146, Stuttgart

186, Stuttgart

211, Stuttgart

226, Tübingen

139, Ulm

172, Unterhaching

239, Westerstede

233, Wiesbaden

122, Wolfach

194, Zwickau

607, Alexandroupoli

600, Athens

602, Athens

605, Athens

610, Athens

608, Chaïdári

611, Marousi

601, Melíssia

604, Thessaloniki

606, Thessaloniki

664, Acquaviva delle Fonti

654, Ancona

665, Bari

655, Cagliari

666, Casarano

662, Cassino

653, Ferrara

661, Imperia

650, Lido di Camaiore

663, Lodi

658, Messina

660, Napoli

667, Pisa

657, Roma

656, San Giovannni Rotondo

669, Torino

704, Aguascalientes

707, Guadalajara

701, Mexico City

702, Mexico City

703, Mérida

706, Monterrey

710, Morelia Michoacan

708, San Luis Potosí City

705, Zapopan

425, Arad

406, Bacau

407, Bacau

417, Bistriţa

412, Bucharest

418, Bucharest

423, Bucharest

424, Bucharest

434, Bucharest

436, Bucharest

427, Constanța

411, Craiova

433, Craiova

404, Drobeta-Turnu Severin

437, Foscani, Jud. Vrancea

405, Galati

420, Galati

403, Lasi

409, Lasi

415, Medgidia

402, Orăştie

401, Piteşti

428, Piteşti

435, Râmnicu Vâlcea

422, Resista

408, Satu Mare

429, Sfântu Gheorghe

413, Sibiu

416, Târgovişte

432, Târgu Mureş

414, Timișoara

421, Timișoara

521, Banská Bystrica

500, Bratislava

502, Bratislava

507, Bratislava

514, Bratislava

501, Dolný Kubín

505, Dubnica nad Váhom

522, Krompachy

520, Lučenec

508, Skalica

503, Spišská Nová Ves

509, Stará Ľubovňa

510, Trenčín

519, Vranov nad Topľou

518, Zvolen

516, Žilina

308, Alzira (Valencia)

320, Badalona

301, Barcelona

303, Barcelona

305, Barcelona

318, Barcelona

315, Burgos

313, Ciudad Real

306, Madrid

307, Madrid

314, Palma de Mallorca

312, Valencia

355, Biel

354, Sankt Gallen

353, Sargans

351, Tschugg

350, Zurich

Sponsors

Lead Sponsor

All Listed Sponsors
lead

UCB Pharma

INDUSTRY

NCT00599339 - Transdermal Rotigotine User Surveillance Study | Biotech Hunter | Biotech Hunter